Stroke can trigger the production of inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), which stimulate osteoclastogenesis and inhibit osteoblast function, leading to accelerated bone resorption and osteoporosis [40–42]. This evidence concerns the gene CRP and stroke disorder.